Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Mar 2026, May 2026, Jun 2026, Jul 2026 and Sep 2026.
- Largest single sale: $368K (4,000 shares) of Oruka Therapeutics, Inc. on Sep 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Jul 1, 2025 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Oruka Therapeutics, Inc.: sold 906 shares for $87K, to cover taxes. 1 filing: 1
- Sep 1, 2026, Oruka Therapeutics, Inc.: sold 5,000 shares for $459K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jul 1, 2026, Oruka Therapeutics, Inc.: sold 5,000 shares for $472K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jun 15, 2026, Oruka Therapeutics, Inc.: sold 600 shares for $42K, to cover taxes. 1 filing: 1
- May 1, 2026, Oruka Therapeutics, Inc.: sold 5,000 shares for $319K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.